Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Denosumab × Dermatologic × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Tumor-Agnostic 1 Head & Neck 1 Genitourinary 1 Endocrine 1 Dermatologic 1 Breast 1

Conditions

Interventions

Nivolumab 24 pembrolizumab 18 Ipilimumab 15 Temozolomide 13 toripalimab 9 Cyclophosphamide 9 Biopsy 9 Blood Specimen Collection 8 Dacarbazine 7 camrelizumab 6 Imiquimod 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 aldesleukin 5 Cisplatin 5 Chemotherapy, Adjuvant 5 fludarabine phosphate 4 durvalumab 4 binimetinib 4 apatinib 4 Sorafenib 4 Interleukin-2 4 Injections 4 Gene Expression Profiling 4 Bevacizumab 4 Aminolevulinic Acid 4 palbociclib 3 methyl 5-aminolevulinate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161756 2022-04-07

CHARLI

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡